Macquarie Group LTD Biolife Solutions Inc Transaction History
Macquarie Group LTD
- $79.1 Billion
- Q2 2025
A detailed history of Macquarie Group LTD transactions in Biolife Solutions Inc stock. As of the latest transaction made, Macquarie Group LTD holds 103,677 shares of BLFS stock, worth $2.76 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
103,677
Previous 104,939
1.2%
Holding current value
$2.76 Million
Previous $2.4 Million
6.8%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding BLFS
# of Institutions
205Shares Held
50.4MCall Options Held
0Put Options Held
0-
Casdin Capital, LLC New York, NY7.71MShares$205 Million23.27% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$146 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.25MShares$113 Million0.06% of portfolio
-
Invesco Ltd. Atlanta, GA3.58MShares$95.2 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.9MShares$77 Million0.0% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.13B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...